134 related articles for article (PubMed ID: 36516333)
1. Oral mucous membrane pemphigoid after SARS-CoV-2 vaccination.
Calabria E; Antonelli A; Lavecchia A; Giudice A
Oral Dis; 2024 Mar; 30(2):782-783. PubMed ID: 36516333
[No Abstract] [Full Text] [Related]
2. Mucous Membrane Pemphigoid Following the Administration of COVID-19 Vaccine.
Rungraungrayabkul D; Rattanasiriphan N; Juengsomjit R
Head Neck Pathol; 2023 Jun; 17(2):587-588. PubMed ID: 36849670
[No Abstract] [Full Text] [Related]
3. DPP4-inhibitor-associated oral mucous membrane pemphigoid.
Thermos G; Katsoulas N; Vilos G; I Tosios K
Oral Dis; 2023 Jul; 29(5):2321-2323. PubMed ID: 35491436
[No Abstract] [Full Text] [Related]
4. Bullous pemphigoid after inactivated COVID-19 vaccination: Case report.
Zhang Y; Lang X; Guo S; He H; Cui H
Dermatol Ther; 2022 Aug; 35(8):e15595. PubMed ID: 35608483
[No Abstract] [Full Text] [Related]
5. Mucous membrane pemphigoid and lichenoid reactions after immune checkpoint inhibitors: common pathomechanisms.
Fässler M; Rammlmair A; Feldmeyer L; Suter VGA; Gloor AD; Horn M; Deml K; Beltraminelli H; Borradori L
J Eur Acad Dermatol Venereol; 2020 Feb; 34(2):e112-e115. PubMed ID: 31660663
[No Abstract] [Full Text] [Related]
6. Chronic oral diseases secondary to COVID-19 infection or vaccination: clinical cases and a narrative review.
Fitzpatrick S; Cha S; Katz J; Migliorati C
Quintessence Int; 2024 May; 55(5):400-411. PubMed ID: 38415994
[TBL] [Abstract][Full Text] [Related]
7. Drug-induced pemphigoid: bullous and cicatricial.
Vassileva S
Clin Dermatol; 1998; 16(3):379-87. PubMed ID: 9642531
[No Abstract] [Full Text] [Related]
8. Reply to: 'Severe bullous pemphigoid following Covid-19 vaccination resistant to rituximab and successfully treated with dupilumab' by Baffa et al.
Sun L; Brazão C; Mancha D; Soares-de-Almeida L; Filipe P
J Eur Acad Dermatol Venereol; 2023 May; 37(5):e578-e580. PubMed ID: 36681888
[No Abstract] [Full Text] [Related]
9. Incident bullous pemphigoid in a psoriatic patient following mRNA-1273 SARS-CoV-2 vaccination.
Hung WK; Chi CC
J Eur Acad Dermatol Venereol; 2022 Jun; 36(6):e407-e409. PubMed ID: 35073431
[No Abstract] [Full Text] [Related]
10. SARS-CoV-2 vaccine-triggered conversion from systemic lupus erythematosus (SLE) to bullous SLE and dipeptidyl peptidase 4 inhibitors-associated bullous pemphigoid.
Nakahara Y; Yamane M; Sunada M; Aoyama Y
J Dermatol; 2023 Feb; 50(2):162-165. PubMed ID: 36578130
[TBL] [Abstract][Full Text] [Related]
11. [Mucocutaneous bullous pemphigoid induced by valsartan. A clinical case].
Femiano F
Minerva Stomatol; 2003 Apr; 52(4):187-90. PubMed ID: 12874527
[TBL] [Abstract][Full Text] [Related]
12. Radiation-Induced Laryngeal Mucous Membrane Pemphigoid.
Syal A; Lott DG; Karle WE
Ann Otol Rhinol Laryngol; 2023 Oct; 132(10):1261-1264. PubMed ID: 36433793
[TBL] [Abstract][Full Text] [Related]
13. Bullous pemphigoid after SARS-CoV-2 vaccination: spike-protein-directed immunofluorescence confocal microscopy and T-cell-receptor studies.
Gambichler T; Hamdani N; Budde H; Sieme M; Skrygan M; Scholl L; Dickel H; Behle B; Ganjuur N; Scheel C; Abu Rached N; Ocker L; Stranzenbach R; Doerler M; Pfeiffer L; Becker JC
Br J Dermatol; 2022 Apr; 186(4):728-731. PubMed ID: 34773638
[No Abstract] [Full Text] [Related]
14. [Reactivation of an ocular mucous membrane pemphigoid due to zoster ophthalmicus and COVID-19].
Stanischewski S; Viestenz A; Heichel J
Ophthalmologie; 2024 Jan; 121(1):72-74. PubMed ID: 37160620
[No Abstract] [Full Text] [Related]
15. Oral manifestations of benign mucous membrane pemphigus (mucous membrane pemphigoid); review of the literature and report of fifteen cases.
SHKLAR G; McCARTHY PL
Oral Surg Oral Med Oral Pathol; 1959 Aug; 12(8):950-66. PubMed ID: 13674694
[No Abstract] [Full Text] [Related]
16. A case of anti-p200 pemphigoid after COVID-19 vaccination.
Shimamoto K; Someda Y; Ushimura A; Tateishi C; Hayashi D; Tsuruta D; Hashimoto T; Goto H
Eur J Dermatol; 2024 Apr; 34(2):220-221. PubMed ID: 38907563
[No Abstract] [Full Text] [Related]
17. Bullous pemphigoid and COVID-19 vaccination: Management and treatment reply to 'Bullous pemphigoid in a young male after COVID-19 mRNA vaccine: A report and brief literature review' by Pauluzzi et al.
Martora F; Ruggiero A; Battista T; Fabbrocini G; Megna M
J Eur Acad Dermatol Venereol; 2023 Jan; 37(1):e35-e36. PubMed ID: 35974447
[No Abstract] [Full Text] [Related]
18. Drug-induced pemphigoid. A spectrum of diseases.
Fiore PM; Jacobs IH; Goldberg DB
Arch Ophthalmol; 1987 Dec; 105(12):1660-3. PubMed ID: 3318771
[TBL] [Abstract][Full Text] [Related]
19. Methotrexate for oral mucous membrane (cicatricial) pemphigoid: experience at an academic dermatology outpatient clinic.
Hrin ML; Williams JA; Bowers NL; Ahn CS; Strowd LC
J Am Acad Dermatol; 2022 Dec; 87(6):1431-1433. PubMed ID: 35948167
[No Abstract] [Full Text] [Related]
20. A case of acquired hemophilia A and bullous pemphigoid following SARS-CoV-2 mRNA vaccination.
Fu PA; Chen CW; Hsu YT; Wei KC; Lin PC; Chen TY
J Formos Med Assoc; 2022 Sep; 121(9):1872-1876. PubMed ID: 35321820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
